- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05190042
Clinical Study on Continuous Suture of Endoscopic Mucosal Defects
March 30, 2024 updated by: Affiliated Hospital to Academy of Military Medical Sciences
Clinical Study on Continuous Suture of Mucosal Defects After Endoscopic Mucosal Lesion Resection
The use of clips to completely clip mucosal defects after ESD/EMR can reduce postoperative adverse events, but the rate of incomplete mucosal defects closure is high.
The continuous suture technique can completely close the mucosal defects by using surgical sutures and clips to suture the mucosal defects after ESD/EMR.
In this study, a clinical randomized controlled study was conducted in our hospital.
A total of 62 enrolled patients were divided into two groups, 31 patients were set as a treatment group using continuous suture technique to close post-EMR/ESD mucosal/submucosal defects, the rest patients were set as a control group using clips.
The safety and effectiveness of continuous sutures and clips to clamp the post-EMR/ESD mucosal/submucosal defect were compared in the two groups.
The complete mucosal/submucosa defects closure rates were the primary outcome.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Endoscopic submucosal resection (EMR) or submucosal dissection (ESD) for gastrointestinal lesions were used to treat early gastrointestinal cancer or large benign polyps, and their complete resection rates were high, which greatly reduce unnecessary surgical operations.
However, after endoscopic resection of mucosal/submucosal lesions, large mucosal/submucosal defects may be created.
These defects may cause more delayed postoperative adverse events (bleeding, perforation).
The use of clips to completely seal the mucosal defect after gastrointestinal mucosal/submucosal lesion resection can significantly reduce postoperative adverse events, but the rate of incomplete mucosal defects closure is high.
The surgical sutures combined with clips to close the mucosal defect after surgery significantly increased the complete closure rates of the post-EMR/ESD mucosal/submucosal defect.
This study intends to further determine its safety and effectiveness through a clinical randomized controlled study, and standardize indications and contraindications.
A total of 62 enrolled patients were allocated into two groups, 31 patients were set as a treatment group using continuous suture technique to close post-EMR/ESD mucosal/submucosal defects, the rest patients were set as a control group using clips.
The safety and effectiveness of continuous sutures and clips to clamp the post-EMR/ESD mucosal/submucosal defect were compared in the two groups.
The primary outcome was complete mucosal/submucosa defects closure rates.
The secondary outcomes were the closure time, closure speed, and immediate bleeding during the operation as well as delayed bleeding, delayed perforation, and polyps syndrome after resection.
Study Type
Interventional
Enrollment (Actual)
62
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Beijing
-
Beijing, Beijing, China, 100039
- The Fifth Medical Center of Chinese PLA General Hosptial
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- The indications for endoscopic resection were large (≥20mm in diameter), nonpedunculated, benign, and early malignant mucosal or submucosal gastric or colorectal lesions.
- Written informed consent
Exclusion Criteria:
- The tumor has spread to the muscularis layer, lymph nodes, or distal metastases;
- Multiple lesions (≥20mm in diameter) ;
- Underlying bleeding disorder;
- The platelet count less than 50×10^9/L;
- Serious cardio-pulmonary, hepatic or renal disease;
- Intolerance to endoscopy;
- Other high-risk conditions or disease (such as massive ascites, etc.);
- Pregnancy.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Continuous suture group
Surgical sutures were used to completely close the post-EMR/ESD mucosal/submucosal defects. This group was set as a experimental group. |
Cotinuous suture using surgery thread
|
|
Active Comparator: Clips group
Clips were used to completely close the post-EMR/ESD mucosal/submucosal defects.
This group was set as a control group.
|
Hemostatic clips
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The rates of complete closure of mucosal/submucosal defects
Time Frame: 1day
|
When the clips were applied next to each other and there were no substantial submucosal areas in the closure line
|
1day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The duration time of closure
Time Frame: 1 day
|
The duration of closure was defined as the interval from insertion of the first clip until complete or incomplete closure
|
1 day
|
|
The closure speed
Time Frame: 1day
|
The closure speed was defined as the resection area divided by 10x the duration of the ligation procedure (cm2 /10 minutes).
|
1day
|
|
Immediate bleeding
Time Frame: 1 day
|
Immediate bleeding refers to those episodes of hemorrhage that occurred during the procedure and lasted more than 30 seconds or required endoscopic treatment.
|
1 day
|
|
Delayed bleeding
Time Frame: 14 days
|
Delayed bleeding was defined as bleeding requiring emergency endoscopic hemostasis or transfusion or the presence of hemoglobin loss≥2 g/dL after EMR/ESD
|
14 days
|
|
Delayed perforation
Time Frame: 14 days
|
Delayed perforation was defined as the presence of free air on abdominal CT or radiography after completion of the procedure in patients without perforation during EMR/ESD and no symptoms of peritoneal irritation after EMR/ESD
|
14 days
|
|
Post polypectomy syndrome
Time Frame: 14 days
|
Post polypectomy syndrome was defined by symptoms of pain, fever, leukocytosis, peritoneal tenderness, and guarding.
|
14 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Yan Liu, MD, Beijing 302 Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 18, 2022
Primary Completion (Actual)
June 30, 2022
Study Completion (Actual)
July 30, 2022
Study Registration Dates
First Submitted
November 23, 2021
First Submitted That Met QC Criteria
December 28, 2021
First Posted (Actual)
January 13, 2022
Study Record Updates
Last Update Posted (Actual)
April 2, 2024
Last Update Submitted That Met QC Criteria
March 30, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 307-GIE-Suture
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gastrointestinal Neoplasms
-
Medstar Health Research InstituteRecruitingGastrointestinal Cancer | Gastrointestinal Tumor | Gastrointestinal Surgery | Gastrointestinal Tumor SurgeryUnited States
-
Sun Yat-sen UniversityUnknownGastrointestinal CancersChina
-
H. Lee Moffitt Cancer Center and Research InstituteNovartisCompleted
-
Peking University Cancer Hospital & InstituteActive, not recruitingGastrointestinal CancerChina
-
Suzhou Zelgen Biopharmaceuticals Co.,LtdJiangsu Alphamab Biopharmaceuticals Co., LtdTerminatedAdvanced Gastrointestinal TumorsChina
-
Boehringer IngelheimCompletedGastrointestinal Cancer, MetastaticBelgium, United States, France, Japan, China
-
Taiho Oncology, Inc.CompletedAdvanced Gastrointestinal TumorsUnited States
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Henan Cancer HospitalUnknownAdvanced Gastrointestinal TumorsChina
-
Apceth GmbH & Co. KGTerminatedAdvanced Gastrointestinal CancerGermany
Clinical Trials on Cotinuous suture
-
Montefiore Medical CenterCompletedSurgical Wound Infection | Complications; Cesarean SectionUnited States
-
Tianjin Eye HospitalRecruitingPrimary PterygiumChina
-
Stanford UniversityTerminatedNasal Obstruction | Nasal Septum; Deviation, CongenitalUnited States
-
Hadassah Medical OrganizationUnknownOral Surgical Procedures
-
Rutgers UniversityCompleted
-
Università degli Studi dell'InsubriaCompletedSurgical Wound DehiscenceItaly
-
Hospital de MataróCompletedHemorrhoids | Rectal Mucosa ProlapseSpain
-
Washington Hospital Healthcare SystemCompletedKnee Osteoarthritis | Hip Osteoarthritis
-
Sun Yat-sen UniversityCompletedSurgery--Complications | Retinoblastoma Bilateral
-
Instituto Mexicano del Seguro SocialCompletedOrbital Floor Fractures | Surgical Wound Closure Techniques | Subciliary Surgical Approach | Postoperative Complications in Maxillofacial SurgeryMexico